Clinical Trial Update: Cognitive Rehabilitation and Galantamine for Post Stroke Cognitive Impairment [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating cognitive rehabilitation with galantamine for post-stroke cognitive impairment has completed, sponsored by INSERM.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment
• Stroke

Drugs mentioned

• Galantamine (galantamine)

Snippet

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France | Conditions: Stroke, Cognitive Impairment | Phase 2 | Status: COMPLETED